等待开盘 08-05 09:30:00 美东时间
+1.470
+1.37%
今日重点评级关注:古根海姆:维持ProMIS Neurosciences"买入"评级,目标价从35美元升至69美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从38美元升至39美元
07-30 11:45
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
HSBC analyst Carlos Laboy downgrades Coca-Cola Femsa SAB de (NYSE:KOF) from Buy to Hold and announces $116 price target.
07-29 00:11
Coca-Cola Femsa (NYSE:KOF) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.68 by 1.19 percent. This is a 30.77 percent increase over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $4.388 billion which...
07-27 21:03
今日重点评级关注:Needham:维持Annexon"买入"评级,目标价从11美元升至25美元;Benchmark:维持Prenetics Global"买入"评级,目标价从30美元升至40美元
07-16 18:55
今日重点评级关注:Keybanc:维持迈威尔科技"超配"评级,目标价从385美元升至400美元;丰业银行:维持科尔黛伦矿业"跑赢大市"评级,目标价从27.5美元升至28.5美元
07-15 10:22
UBS analyst Rodrigo Alcantara maintains Coca-Cola Femsa SAB de (NYSE:KOF) with a Neutral and lowers the price target from $113 to $110.
07-15 00:46
最高股息率超10%!惠普、辉瑞、英美烟草等40家公司即将分红,投资者若想赚取股息,可趁未除净适时部署,一文速览派息名单>>
07-01 17:31
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
JP Morgan analyst Lucas Ferreira maintains Coca-Cola Femsa SAB de (NYSE:KOF) with a Neutral and raises the price target from $110 to $114.
05-27 01:39